0.5 mg: Sweet spot for many CrossFitters
Int J Clin Pract 73(8):e13248
Your skin is always listening
Small-molecule inhibitors of cGAS enzymatic activity (e.g., RU.521, G140, PF-06928215) or STING signaling (e.g., H-151, C-176) have shown promise in preclinical neuroinflammation and neurodegeneration models by suppressing excessive type I interferon and cytokine production [12, 196]
BPC-157 primarily works at the genetic level to increase actin production and growth factor expression, while TB-500 functions as an actin-binding protein that facilitates cellular movement and migration
Last year, Prime published data that found 32% of patients were still taking a GLP-1 medicine for weight loss 12 months after their initial prescription